Article
Mutagenic consequences of the incorporation of 6-thioguanine into DNA.
Biochemical pharmacology - 1 Aug 1997
Uribe-Luna S, Quintana-Hau J D, Maldonado-Rodriguez R, Espinosa-Lara M, Beattie K L, Farquhar D, Nelson J A
Abstract excerpt
6-Thioguanine (S6G) has been used in the treatment of acute leukemias because of its cytotoxic effect on proliferating leukemic cells. The cytotoxicity of S6G is thought to derive from its incorporation into DNA in place of guanine. The deoxyribonucleoside triphosphate of S6G, SdGTP, is a good substrate for bacterial and human DNA polymerases (Ling et al., Mol Pharmacol 40: 508-514, 1991). Since SdGTP was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
